Sector Update: Healthcare Shares Higher in Pre-Market; Amarin Up 3% on Vascepa Trial Results

By Staff,

Shutterstock photo

Health care stocks:

JNJ: +0.47%

PFE: +0.33%

ABT: +0.65%

MRK: +0.48%

AMGN: +0.82%

Healthcare shares are rebounding pre-market, with shares of Amarin Corporation ( AMRN ) up 3% at $6.46. The company late yesterday announced the results from a Phase 1 clinical trial that compared bioavailability of components from a fixed-dose combination of its flagship product, Vascepa, plus rosuvastatin, to concomitant administration of the two agents independently, and to rosuvastatin alone.

In other healthcare stocks news, Oramed Pharmaceuticals Inc. ( ORMP ) says it has withdrawn the previously announced proposed underwritten public offering of its common stock due to market conditions. ORMP is flat at $5.42 in pre-market trade.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing Commodities
Referenced Stocks: AMRN , ORMP

More from MT Newswires


MT Newswires

MT Newswires

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by